IDiyas

For the Inventor, By the Inventor

Rome, Italy

Mariangela Biava

USPTO Granted Patents = 5

 

Average Co-Inventor Count = 5.9

ph-index = 1


Location History:

  • Siena, IT (2011)
  • Rome, IT (2011 - 2015)

Company Filing History:

goldMedal1 out of 15 
 
Rottapharm Biotech S.r.l.
 patents
silverMedal1 out of 56 
 
Università Degli Studi Di Roma "La Sapienza"
 patents
bronzeMedal1 out of 18 
 
Universitá Degli Studi Di Siena
 patents
4. 1 out of 1 
 
Universta' Degli Studi Di Siena
 patent
5. 1 out of 26 
 
Rottapharm Spa
 patents
6. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 9162979 - 1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors (2015-10-20),
2. 8304410 - Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto (2012-11-06),
3. 8012970 - Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine, synthesis process and uses thereof (2011-09-06),
4. 7910581 - Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl] methyl}-4-methylpiperazine, synthesis process and uses thereof (2011-03-22),
5. 7906551 - 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors (2011-03-15),

Title: Innovations by Mariangela Biava

Introduction

Mariangela Biava is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective COX-2 inhibitors and nitric oxide donors. With a total of five patents to her name, her work has the potential to impact medical treatments significantly.

Latest Patents

Among her latest patents are the 1,5-Diaryl-2-alkylpyrrole-3-substituted nitro esters. These compounds are recognized for their potency as selective COX-2 inhibitors, which can release nitric oxide in concentrations that mitigate the side effects associated with selective COX-2 inhibition. The formula includes various substituents that enhance the efficacy of these compounds, making them valuable in pharmaceutical formulations.

Career Highlights

Mariangela Biava has worked with notable organizations such as Rottapharm Biotech S.r.l. and Università Degli Studi Di Roma “La Sapienza.” Her experience in these institutions has allowed her to advance her research and contribute to innovative solutions in the pharmaceutical industry.

Collaborations

Some of her notable collaborators include Giulio Cesare Porretta and Raffaello Pompei. Their joint efforts have furthered the development of her inventions and expanded the scope of her research.

Conclusion

Mariangela Biava's contributions to the field of pharmaceuticals through her innovative patents demonstrate her expertise and commitment to advancing medical science. Her work continues to pave the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…